ContextVision broadens Digital Pathology Advisory Board

STOCKHOLM – November 8, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has added new members to its advisory board for DESUTO, a Eurostar sponsored research program within digital pathology. Professor Junya Fukuoka of the Department of Pathology in Nagasaki and Professor Fredrik Pontén of Uppsala University have both […]
Read More

ContextVision joins partnership to develop new image database

The Centre for Medical Imaging Science and Visualization (CMIV) at Linköping University is developing a new database for medical images and pathology images to offer training data for new artificial intelligence-based (AI) products. As an early partner, ContextVision and one other company, Sectra, will have the opportunity to create commercial value from the database. New, […]
Read More

ContextVision secures large-scale data source for digital pathology research and development

STOCKHOLM – March 29, 2017 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, has started a collaboration and signed an agreement with ALABplus, one of Poland’s largest provider of pathology services, to secure access to a significant amount of data for deep learning product development within digital pathology. “The present […]
Read More

ContextVision/HES-SO Team among Top Three in Prestigious Competition using Deep Learning in Digital Pathology

STOCKHOLM – Oct. 18, 2016 – ContextVision, a medical technology company specializing in image analysis and artificial intelligence, placed top three among automated image analysis in the Tumor Proliferation Assessment Challenge (TUPAC) 2016 competition with its SLDESUTO partner (HES-SO). Many prestigious teams participated, including both highly reputable academic teams and research groups from companies like […]
Read More

ContextVision files new patent for digital pathology

This important step in ContextVision’s deep learning strategy generates the opportunity for a leading role within digital pathology, a market estimated to be worth $157 million USD by 2018. STOCKHOLM – June 29, 2016 – ContextVision, the leading provider of medical image processing software, has filed a patent for a new method using high-precision deep learning […]
Read More

ContextVision awarded research grant to develop new technology

ContextVision AB (OSE: COV), the medical imaging software company, has together with its academic partner been awarded a research grant of € 683,000 for a research program aimed at developing new imaging technology within prostate cancer and digital pathology. The technology under development is expected to expand ContextVision’s market footprint significantly. The research program is […]
Read More